Compare National Perox. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -24.68% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 2.63% signifying low profitability per unit of shareholders funds
With a growth in Net Profit of 333.33%, the company declared Very Positive results in Mar 26
With ROE of 3.2, it has a Attractive valuation with a 0.9 Price to Book Value
Majority shareholders : Promoters
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 325 Cr (Micro Cap)
29.00
45
0.00%
-0.16
3.21%
0.94
Total Returns (Price + Dividend) 
Latest dividend: 12.5 per share ex-dividend date: Aug-20-2024
Risk Adjusted Returns v/s 
Returns Beta
News
When is the next results date for National Peroxide Ltd?
The next results date for National Peroxide Ltd is scheduled for August 3, 2026....
Read full news article
National Peroxide Ltd Downgraded to Sell Amid Mixed Financials and Bearish Technicals
National Peroxide Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a shift in technical indicators and concerns over its long-term fundamental strength despite recent positive quarterly results. The company’s micro-cap status, combined with bearish technical trends and subdued profitability metrics, has prompted a reassessment of its outlook by MarketsMOJO.
Read full news article
National Peroxide Ltd is Rated Hold
National Peroxide Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article Announcements 
Cancellation of Board Meeting
02-Aug-2026 | Source : BSEThe Board Meeting to be held on 03/08/2026 Stands Cancelled.
Board Meeting Intimation for Approval Of Unaudited Financial Results For Quarter Ended 30Th June 2026.
29-Jul-2026 | Source : BSENational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 inter alia to consider and approve Unaudited Financial Results for quarter ended 30th June 2026.
Announcement under Regulation 30 (LODR)-Change in Management
15-Jul-2026 | Source : BSEPlease find attached resignation of Chief Information Officer of the Company.
Corporate Actions 
No Upcoming Board Meetings
National Peroxide Ltd has declared 125% dividend, ex-date: 20 Aug 24
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Nowrosjee Wadia And Sons Limited (33.08%)
None
24.82%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 24.01% vs 1.17% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 333.33% vs 369.23% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -10.64% vs -6.39% in Sep 2024
Growth in half year ended Sep 2025 is -77.78% vs -35.64% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -4.29% vs -12.97% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -26.65% vs -69.10% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.99% vs -13.85% in Mar 2025
YoY Growth in year ended Mar 2026 is 590.67% vs -113.40% in Mar 2025






